ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Baronsmead Second Venture Trust Plc

Baronsmead Second Venture Trust Plc (BMD)

53.50
0.00
(0.00%)
Closed January 05 10:30AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
53.50
Bid
52.50
Ask
54.50
Volume
0.00
53.50 Day's Range 53.50
52.00 52 Week Range 58.00
Market Cap
Previous Close
53.50
Open
53.50
Last Trade
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
35,799
Shares Outstanding
396,183,675
Dividend Yield
7.48%
PE Ratio
-30.75
Earnings Per Share (EPS)
-0.02
Revenue
-1.2M
Net Profit
-6.91M

About Baronsmead Second Venture Trust Plc

Sector
Trust,ex Ed,religious,charty
Industry
Trust,ex Ed,religious,charty
Headquarters
London, Gbr
Founded
-
Baronsmead Second Venture Trust Plc is listed in the Trust,ex Ed,religious,charty sector of the London Stock Exchange with ticker BMD. The last closing price for Baronsmead Second Venture was 53.50p. Over the last year, Baronsmead Second Venture shares have traded in a share price range of 52.00p to 58.00p.

Baronsmead Second Venture currently has 396,183,675 shares outstanding. The market capitalization of Baronsmead Second Venture is £211.96 million. Baronsmead Second Venture has a price to earnings ratio (PE ratio) of -30.75.

BMD Latest News

Baronsmead Second Venture Trust PLC Director Declaration

Baronsmead Second Venture Trust PLC 03 January 2025     3 January 2025     Baronsmead Second Venture Trust plc ("BSVT" or the "Company")   Directorate Declaration   As required by Listing Rule...

Baronsmead Second Venture Trust PLC Total Voting Rights

Baronsmead Second Venture Trust PLC 02 January 2025   2 January 2025   Baronsmead Second Venture Trust plc (the "Company") Voting Rights and Capital In accordance with the FCA's Disclosure...

EARNINGS: Mendell Helium loss narrows; Chenavari Toro profit grows

The following is a round-up of earnings for London-listed companies, issued on Monday, Tuesday and not separately rep ...

Baronsmead Second Venture Trust PLC Annual Financial Report

Baronsmead Second Venture Trust PLC 24 December 2024   Baronsmead Second Venture Trust plc   Annual Report and Audited Financial Statements for the year ended 30 September 2024   The Directors...

Baronsmead Second Venture Trust PLC Transaction in Own Shares

Baronsmead Second Venture Trust PLC 19 December 2024   19 December 2024   Baronsmead Second Venture Trust plc (the "Company")   Transaction in Own Shares       The Company announces that on 19...

Baronsmead Second Venture Trust PLC Director Declaration

Baronsmead Second Venture Trust PLC 12 December 2024     12 December 2024     Baronsmead Second Venture Trust plc ("BSVT" or the "Company")   Directorate Declaration   As required by Listing...

Baronsmead Second Venture Trust PLC Net Asset Value(s)

Baronsmead Second Venture Trust PLC 05 December 2024   The Board of Baronsmead Second Venture Trust plc (the "Company") announces that the unaudited net asset value of the Ordinary Shares as...

Baronsmead Second Venture Trust PLC Total Voting Rights

Baronsmead Second Venture Trust PLC 02 December 2024   2 December 2024   Baronsmead Second Venture Trust plc (the "Company") Voting Rights and Capital In accordance with the FCA's Disclosure...

Baronsmead Second Venture Trust PLC Update on Offer for Subscription

Baronsmead Second Venture Trust PLC 26 November 2024     NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, THE REPUBLIC...

Baronsmead Second Venture Trust PLC Compliance with UK Market Abuse Regulation

Baronsmead Second Venture Trust PLC 22 November 2024   22 November 2024 Baronsmead Second Venture Trust plc (the "Company") Compliance with UK Market Abuse Regulation ("UK MAR") The Company...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10053.553.553.5124353.5DE
4-1-1.8348623853254.554.553.55578253.56924849DE
12-1.5-2.727272727275555.552.53579954.59096741DE
26-3-5.3097345132756.557.552.52308455.2383981DE
52-1-1.8348623853254.558522102355.71858302DE
156-26-32.704402515779.58249.62768961.19798216DE
260-22-29.139072847775.587.7549.63102267.20219746DE

BMD - Frequently Asked Questions (FAQ)

What is the current Baronsmead Second Venture share price?
The current share price of Baronsmead Second Venture is 53.50p
How many Baronsmead Second Venture shares are in issue?
Baronsmead Second Venture has 396,183,675 shares in issue
What is the market cap of Baronsmead Second Venture?
The market capitalisation of Baronsmead Second Venture is GBP 211.96M
What is the 1 year trading range for Baronsmead Second Venture share price?
Baronsmead Second Venture has traded in the range of 52.00p to 58.00p during the past year
What is the PE ratio of Baronsmead Second Venture?
The price to earnings ratio of Baronsmead Second Venture is -30.75
What is the cash to sales ratio of Baronsmead Second Venture?
The cash to sales ratio of Baronsmead Second Venture is -178.33
What is the reporting currency for Baronsmead Second Venture?
Baronsmead Second Venture reports financial results in GBP
What is the latest annual turnover for Baronsmead Second Venture?
The latest annual turnover of Baronsmead Second Venture is GBP -1.2M
What is the latest annual profit for Baronsmead Second Venture?
The latest annual profit of Baronsmead Second Venture is GBP -6.91M
What is the registered address of Baronsmead Second Venture?
The registered address for Baronsmead Second Venture is 5 NEW STREET SQUARE, LONDON, EC4A 3TW
What is the Baronsmead Second Venture website address?
The website address for Baronsmead Second Venture is www.baronsmeadvcts.co.uk
Which industry sector does Baronsmead Second Venture operate in?
Baronsmead Second Venture operates in the TRUST,EX ED,RELIGIOUS,CHARTY sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TCFTheracryf Plc
0.725p
(38.10%)
7.56M
NMTNeometals Ltd
3.50p
(27.27%)
346.81k
SCHOScholium Group Plc
44.00p
(25.71%)
30.65k
FABFusion Antibodies Plc
10.15p
(24.54%)
3.34M
PYXPyx Resources Limited
3.49p
(22.24%)
8.43k
TM1Technology Minerals Plc
0.125p
(-24.24%)
37.21M
QUIZQuiz Plc
0.70p
(-18.60%)
3.67M
SYMESupply@me Capital Plc
0.003p
(-17.81%)
168.35M
OBDOxford Biodynamics Plc
1.20p
(-14.29%)
827.83k
ZENZenith Energy Ltd.
5.25p
(-13.93%)
5.39M
TRPTower Resources Plc
0.0395p
(5.33%)
539.51M
CPXCap-xx Limited
0.1825p
(1.39%)
494M
NTVONativo Resources Plc
0.0019p
(0.00%)
320.16M
DGIDg Innovate Plc
0.0225p
(-13.46%)
208.21M
ENETEthernity Networks Ltd
0.1125p
(2.27%)
207.56M

Discussion

View Full Feed
Mr. Bill Mr. Bill 16 minutes ago
https://www.goodrx.com/well-being/sleep/how-to-sleep-with-sciatica
nowwhat2 nowwhat2 18 minutes ago
Could still just be climbing in sympathy w overall crypto mkt

Scathingly poor outlooks

https://www.youtube.com/watch?v=EOsjnOUAw14



https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg

WONDF
DonVance DonVance 20 minutes ago
This will hit 1k this year I believe now.
MSTR
georgejjl georgejjl 20 minutes ago
How many of the 7 million Alzheimer’s patients in the USA are projected to be treated with the MAB infusions during 2025???

How many people with Alzheimer’s in the USA are projected to be treated with donepezil (Aricept) or memantine during 2025???

The treatment used t
AVXL
Mr. Bill Mr. Bill 21 minutes ago
Stretches https://www.healthline.com/health/back-pain/sciatic-stretches#sitting-spinal-stretch
Graniteguy Graniteguy 22 minutes ago
Doc and Investor posters here tend to be negatively biased which you whole heartedly champion, especially "Doc" who's medical opinion is at best questionable, and incredibly biased, to fit a narrative of constant failure for Anavex's Blarcamesine. The fact that you pile onto their "steaming pile of
AVXL
BDEZ BDEZ 24 minutes ago
The Russes hit the jackpot?
BDEZ BDEZ 25 minutes ago
40% of homicides in the US take place in districts with a Soros-funded prosecutor.

Biden gave him a Medal Of Freedom.

https://x.com/EndWokeness/status/1875725808071012529
BDEZ BDEZ 26 minutes ago
Not good, thanks for sharing.
sand sand 33 minutes ago
Thank you Ducci for all your sharing and insights extremely helpful. I'm slowly diligently getting there rewiring the brain and focusing on what shows the moves. Much continued success this week. Thank you again.
SPY
mining101 mining101 33 minutes ago
Moving hard soon 
EFSH
mining101 mining101 34 minutes ago
Superb
MEGL
benz280c benz280c 41 minutes ago
Speak louder and maybe you will convince somebody that this is how you really feel. No need to be insecure around your fellow investors.
GDVM
rx7171 rx7171 48 minutes ago
In addition MABs are approved for only a limited portion of the AD population, whereas Blarcamasine appears to be effective in 70-80% of the ITT population with its strongest efficacy in the 70% with wild type Sigma-1.
AVXL
TheHound TheHound 49 minutes ago
Learn how to use the bull market support band with that chart and you’ll have a powerful tool under your belt!
XRPUSD
Investor2014 Investor2014 52 minutes ago
When I say that the totality of information is what Anavex rely on it does take into account the pretty ineffective SOC, associated risks and inconveniences for patients.

Still any drug regulatory process must and should look carefully at the data to ensure that neither type one or tw
AVXL
nowwhat2 nowwhat2 57 minutes ago
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
BTCUSD
rx7171 rx7171 58 minutes ago
Yes that spike to $23 in June of 2021 was driven entirely by the excellent Phase II data for PDD.

Yet now after completing the AD 2b/3 trial and having an EMA MAA accepted for evaluation the share price is barely half that number!

I understand the company being very ca
PDD
sunspotter sunspotter 1 hour ago
Black Cat Moan was one of my favorites back in the day:

https://youtu.be/cxN-frB1UbI?si=Ph6XMC3omR0rRlmR

Edit: auto correct changed Moan to Moana. The cultural prevalence of Disney.
Investor2014 Investor2014 1 hour ago
The ex-biotech executive is back in the Rett trap posting mode - hope it goes better with the biased approach this time.

Listing all the site PI’s is not world class peer review WGT confirmation.
AVXL
nowwhat2 nowwhat2 1 hour ago
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
sunspotter sunspotter 1 hour ago
I rather think you missed the point. It’s not that higher doses of GALT’s drug are toxic, it’s that they are ineffective.

Given the purported mechanism, that almost certainly means lower doses are too, and that the implication that the lower dose worked is merely an artefact.
GALT
nowwhat2 nowwhat2 1 hour ago
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
XRPUSD

Your Recent History

Delayed Upgrade Clock